2016
DOI: 10.1177/0333102415590239
|View full text |Cite
|
Sign up to set email alerts
|

Diet and nutraceutical interventions for headache management: A review of the evidence

Abstract: Background The use of complementary and alternative medicines (CAM) is common among patients with primary headaches. In parallel, CAM research is growing. Diet interventions comprise another category of non-pharmacologic treatment for primary headache that is of increasing clinical and research interest. Methods A literature search was carried out to identify studies on the efficacy of diet and nutraceutical interviews for primary headache in the pediatric and adult populations. MEDLINE, Embase and EBM Reviews… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
34
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(36 citation statements)
references
References 116 publications
0
34
1
Order By: Relevance
“…With regard to the cost for acute medications, in addition to the higher cost herein reported, our data could be used to define an average cost per dose for each of the three main categories of overused drugs: analgesics/non-steroidal anti-inflammatory drugs (around €0.40), triptans (around €6) and opioids (around €0.55). Finally, our results point out the relevance of direct non-medical costs, which received no attention in the evaluation of the cost of headache disorders [6,18,19], and of non-pharmacological treatment, which is increasingly used in the treatment of headache disorders [20][21][22].…”
Section: Discussionmentioning
confidence: 87%
“…With regard to the cost for acute medications, in addition to the higher cost herein reported, our data could be used to define an average cost per dose for each of the three main categories of overused drugs: analgesics/non-steroidal anti-inflammatory drugs (around €0.40), triptans (around €6) and opioids (around €0.55). Finally, our results point out the relevance of direct non-medical costs, which received no attention in the evaluation of the cost of headache disorders [6,18,19], and of non-pharmacological treatment, which is increasingly used in the treatment of headache disorders [20][21][22].…”
Section: Discussionmentioning
confidence: 87%
“…53 Common products include riboflavin, co-enzyme Q10, magnesium, butterbur, feverfew, and omega 3 polyunsaturated fatty acids. 54 We reviewed one systematic review, eight RCTs, and one cross sectional study on the use of natural products in the management of headache.…”
Section: Safetymentioning
confidence: 99%
“…72 Additional manipulations of the diet have been evaluated in headache, although mostly through observational studies and multi-intervention programs from which the dietary effect cannot be elucidated independently. 54 Obesity is associated with an increased risk of headache, including a 40-80% increase risk of migraine. 73 Data are lacking on whether weight loss in obese patients improves headache, although a prospective RCT is under way.…”
Section: Supplements Botanicals and Diet Alterationmentioning
confidence: 99%
“…6,7 Obesity increases the risk of migraine converting from episodic to chronic. In addition, migraine and obesity are highly co-morbid.…”
Section: Migrainementioning
confidence: 99%